{"cluster": 48, "subcluster": 68, "abstract_summ": "RESULTS We identified 1040 COVID-19 patients (mean age 38 years, 54% men), 1670 SARS patients (mean age 44 years, 44% men) and 675 other HCoV patients (mean age 20 years, 57% men).Older age, male, multiple pre-existing comorbidities, lymphopenia, increased infection indicators, elevated D-dimer, and impaired heart and liver functions were the risk factors of AKI.ALT/AST elevation occurred in 50.3% SARS patients, 22.5% COVID-19 patients and 36.0% other HCoV patients.Results Fifty-five patients (37.2%) had abnormal liver function at hospital admission; 14.5% of these patients had high fever (14.5%), compared with 4.3% of patients with normal liver function (P=.027).In multivariable analysis, severe acute liver injury was significantly associated with elevated inflammatory markers including ferritin (OR 2.40, p<0.001) and IL\u20106 (OR 1.45, p=0.009).", "title_summ": "Abnormal liver function tests predict transfer to intensive care unit and death in COVID\u201019Longitudinal association between markers of liver injury and mortality in COVID\u201019 in ChinaClinical Features of COVID-19-Related Liver DamageKidney disease is associated with in-hospital death of patients with COVID-19Do underlying cardiovascular diseases have any impact on hospitalised patients with COVID-19?ACUTE KIDNEY INJURY IN PATIENTS HOSPITALIZED WITH COVID-19The role of essential organ-based comorbidities in the prognosis of COVID-19 infection patientsCoronavirus disease 2019: acute Fanconi syndrome precedes acute kidney injuryAcute Kidney Injury in Hospitalized Patients with COVID-19Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)Increased serum aminotransferase activity and clinical outcomes in Coronavirus disease 2019Clinical characteristics of non\u2010ICU hospitalized patients with coronavirus disease 2019 and liver injury: A retrospective studyEvaluation of organ function in patients with severe COVID-19 infectionsAcute Liver Injury in COVID\u201019: Prevalence and Association with Clinical Outcomes in a Large US CohortPattern of liver injury in adult patients with COVID-19: a retrospective analysis of 105 patientsCharacterization of acute kidney injury in critically ill patients with severe coronavirus disease 2019Hypoalbuminemia predicts the outcome of COVID\u201019 independent of age and co\u2010morbidityPre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)Abnormal liver tests in patients hospitalized with Coronavirus disease 2019: should we worry?Impact of COVID-19 on liver function: results from an internal medicine unit in Northern ItalyKidney manifestations of mild, moderate and severe coronavirus disease 2019: a retrospective cohort studyLiver Biochemistries in Hospitalized Patients With COVID-19.Kidney impairment is associated with in-hospital death of COVID-19 patientsDynamic liver function indexes monitoring and clinical characteristics in three types of COVID-19 patientsCharacterisation of Acute Kidney Injury in Critically Ill Patients with Severe Coronavirus Disease-2019 (COVID-19)Caution on Kidney Dysfunctions of COVID-19 PatientsHeart injury signs are associated with higher and earlier mortality in coronavirus disease 2019 (COVID-19)Acute liver injury and its association with death risk of patients with COVID-19: a hospital-based prospective case-cohort studyAcute kidney injury in patients hospitalized with COVID-19 in Wuhan, China: A single-center retrospective observational studyAcute gastrointestinal injury in critically ill patients with coronavirus disease 2019 in Wuhan, ChinaAnalysis of early renal injury in COVID-19 and diagnostic value of multi-index combined detectionAcute kidney injury at early stage as a negative prognostic indicator of patients with COVID-19: a hospital-based retrospective analysisRisk factors related to hepatic injury in patients with corona virus disease 2019Urinalysis, but not blood biochemistry, detects the early renal-impairment in patients with COVID-19COVID-19 and Acute Kidney Injury requiring Kidney Replacement Therapy: A Bad Prognostic Sign.Fatal Outcomes of COVID-19 in Patients with Severe Acute Kidney Injury.Liver Enzyme Elevation in Coronavirus Disease 2019: A Multicenter, Retrospective, Cross-Sectional Study.[Clinical characteristics and risk factors of acute kidney injury in coronavirus disease 2019].Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19.Patterns of liver injury in COVID-19 - a German case series.Renal Involvement and Early Prognosis in Patients with COVID-19 Pneumonia.", "title_abstract_phrases": "RESULTS We identified 1040 COVID-19 patients (mean age 38 years, 54% men), 1670 SARS patients (mean age 44 years, 44% men) and 675 other HCoV patients (mean age 20 years, 57% men).Older age, male, multiple pre-existing comorbidities, lymphopenia, increased infection indicators, elevated D-dimer, and impaired heart and liver functions were the risk factors of AKI.ALT/AST elevation occurred in 50.3% SARS patients, 22.5% COVID-19 patients and 36.0% other HCoV patients.Results Fifty-five patients (37.2%) had abnormal liver function at hospital admission; 14.5% of these patients had high fever (14.5%), compared with 4.3% of patients with normal liver function (P=.027).A minority of patients (18.6%) were obese, and most patients were non- or moderate-drinkers (88.5%)."}